IRVING, Texas, April 25, 2025 /PRNewswire/ -- Commercial Metals Company (NYSE: CMC) ("CMC") plans to launch a proposed tax-exempt bond financing today in the amount of $150.0 million. In connection with the proposed financing, the West Virginia Economic Development Authority (the "WVEDA") authorized the issuance and sale of Solid Waste Disposal Facility Revenue Bonds (Commercial Metals Company Project), Series 2025 (the "Bonds"). If the financing is completed, WVEDA will issue the Bonds and loan the proceed ...

SHELTON, Conn., April 25, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (NASDAQ: INTS), ("Intensity" or the "Company") a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies designed to kill tumors and increase immune system recognition of cancers, today announced the pricing of its "reasonable best efforts" public offering with participation from certain new and existing institutional and accredited investors ...

DAYTONA BEACH, Fla., April 25, 2025 (GLOBE NEWSWIRE) -- TopBuild Corp. (NYSE:BLD), a leading installer and specialty distributor of insulation and building material products to the construction industry in the United States and Canada, today announced that it has earned certification by Great Place to Work® for the third consecutive year. Great Place to Work is a global authority on workplace culture, employee experience, and effective leadership, providing independent company assessments based employees' d ...

NEW YORK, April 25, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $30.7 million or $2.93 basic earnings per share for the first quarter of 2025, compared with net income of $26.1 million or $2.50 basic earnings per share for the first quarter of 2024. Revenue for the first quarter of 2025 was $367.8 million, an increase of 4.2%, compared to revenue of $353.1 million for the first quarter of 2024. Albert G. Lowenthal, Chairman and CEO comment ...

TARPON SPRINGS, Fla., April 25, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway inhibitor—as a personalized cancer treatment using its proprietary, drug-specific Drug Response Predictor (DRP®) patient selection technology today announced the presentation of a poster containing data on a new DRP for the monoclonal antibody drug daratumumab. The post ...

GRAND CAYMAN, Cayman Islands, April 25, 2025 (GLOBE NEWSWIRE) -- Oxbridge Re Holdings Limited (Nasdaq: OXBR) (“Oxbridge Re”), together with its subsidiary SurancePlus, is engaged in the tokenization of Real-World Assets (“RWAs”), initially with tokenized reinsurance securities and in providing reinsurance solutions to property and casualty insurers in the Gulf Coast region of the United States. The company today announced its participation in TOKEN2049 Dubai, one of the world’s premier blockchain events, ta ...

CAMBRIDGE, Mass., April 25, 2025 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 1, 2025, to report its first quarter 2025 financial results and provide a corporate update. To access the live conference call, please dial 833-470-1428 (domestic) or 404-975-4839 (international) and refer to conference ID 082088. A webcast of the call will also be available under "Events and Presentations" in th ...

文章核心观点 公司宣布因任命Eric Poma博士为首席执行官，薪酬委员会和董事会批准授予其非合格股票期权 [1] 公司动态 - 公司薪酬委员会和董事会批准授予Eric Poma博士非合格股票期权，可购买726,412股，行权价为0.469美元，授予日期为2025年4月22日 [1] - 股票期权分四年归属，25%在授予日一周年（2026年4月22日）归属，其余按月等额归属直至2029年4月22日，受股票期权协议条款约束 [2] 公司介绍 - 公司是临床阶段免疫肿瘤公司，拥有专有技术，利用异体干细胞携带溶瘤病毒用于多种肿瘤适应症，包括高级别胶质瘤和实体瘤 [3] - 临床阶段即用型通用细胞递送平台可保护、扩增和增强溶瘤病毒，提高疗效和患者安全性，临床前即用型包膜病毒疗法可靶向播散性实体瘤，双管齐下可治疗或预防转移性疾病 [3] 公司联系方式 - 公司企业传播联系人为Dave Gentry，来自RedChip Companies, Inc.，联系电话1 - 407 - 644 - 4256，邮箱CLDI@redchip.com [5]

SINGAPORE, April 25, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, will announce full year 2024 financial results on Wednesday, April 30, 2025, prior to market open. Management will host a live webcast to discuss the results at 8:00 AM Eastern Time / 8:00 PM Singapore Time on Wednesday, April 30, 2025. Management will also provide updates on its AI-Powered Genius Curriculum, Genius City model, Bitcoi ...

Presentation to highlight how AP3 Generative Phosphoproteomic analyses uncover how ACR-2316 induces mitotic and replicative tumor cell death, and the mechanisms underlying its superior potency observed preclinically Phase 1 trial of ACR-2316 ahead of schedule with three dose-escalation cohorts completed; solid tumor shrinkage already observed at dose level three, well below the projected recommended Phase 2 dose WATERTOWN, Mass., April 25, 2025 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “A ...